CubaPLUS Magazine

The work done by the medical staff of the intensive care rooms and the researchers tested the efficacy of proven drugs have allowed that no Covid-19 deaths have been reported in Cuba in the last 10 days, health and scientific authorities said.

On the Mesa Redonda (Round Table) radio and TV program on Tuesday, Eduardo Martinez, president of BioCubaFarma business group, explained the impact of the contributions of the Cuban science, which has been developed to fight the disease, since the first cases with the novel SARS-Cov2 coronavirus (asymptomatic or not) were detected to the treatment to the mild, serious and critical patient.

Martinez explained that since the virus emerged to date, the results in the use of different drugs such as Biomodulin T, an innumupotentiator present throughout the country's national system, is evident, so acute respiratory infections have been reduced by 80% in nursing homes and psychiatric hospitals.

The distribution of more than two million of the homeopathic medicine PrevengHo-Vir, more than 100,000 doses of the transfer factor that strengthen the body's defenses and the use of Interferon nasal spray for health and medical staff and Interferon in vaccine for already infected patients, he said.

The doctor highlighted that international scientific publications collect clinical evaluations that recognize the effectiveness of Interferon Alfa 2B, beta and gamma, with a low lethality among patients to whom it was applied, which dismisses the campaigns against them that tried to discredit it, even when the World Health Organization included it in its protocols.

Martinez noted that among the drugs to treat Covid-19 patients is the monoclonal antibody Itolizumab, which is currently being assessed in a clinical study in India due to its encouraging results.

CIGB 258 is another contribution of the Cuban science, it stops cytokine storm in coronavirus patients and the consequences of a negative development, in addition to avoiding thrombosis due to the immune response that stimulates more than 90% in seriously ill patients and 76% in critical cases.

About this issue, Martinez highlighted the availability that the Cuban pharmaceutical industry maintains to guarantee the necessary medications to treat the Covid-19 disease, despite the limitations to purchase raw materials due to the US blockade and the emergence of a local transmission infection in AICA laboratories, already controlled by health professionals and the measures adopted.